Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Cancer Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1562282

Epidemiology and Clinical Outcomes of Clinically Suspected Multiple Endocrine Neoplasia Type 1 in South Korea: a Nationwide Cohort Study

Provisionally accepted
  • 1College of Medicine, Korea University, Seoul, Republic of Korea
  • 2College of Medicine, Yonsei University, Seoul, Seoul, Republic of Korea
  • 3College of Medicine, Hanyang University, Seoul, Seoul, Republic of Korea
  • 4Yonsei University Health System, Seoul, Republic of Korea

The final, formatted version of the article will be published soon.

Background: Multiple endocrine neoplasia type 1 (MEN1) is a rare hereditary disorder characterized by multiorgan endocrine tumors, primarily affecting the parathyroid glands, pituitary, and pancreas. Despite its clinical significance, the epidemiology and outcomes of clinically suspected MEN1 in Asian populations remain limited. This study aimed to investigate the prevalence, comorbidities, and mortality risk associated with clinically suspected MEN1 in South Korea. Methods: We conducted a retrospective cohort study using the Korean National Health Insurance Service database (2003-2020), identifying clinically suspected MEN1 cases via two operational definitions: (1) ICD-10 MEN1 code (D44.8) with medical service records and (2) diagnoses or interventions for at least two MEN1-associated conditions (primary hyperparathyroidism, pituitary adenoma, or duodenopancreatic neuroendocrine tumors). Cases (n = 412) were matched 1:10 with controls (n = 4,120) by age, sex, and index year. Clinical characteristics, comorbidities, and mortality were analyzed using Kaplan-Meier survival analysis and multivariable Cox regression.The incidence of clinically suspected MEN1 peaked in individuals aged 40-49 years, with a higher prevalence in females (64.6%). Parathyroid involvement was the most common manifestation (58.6%), followed by pituitary (22.3%) and duodenopancreatic tumors (19.9%).Comorbidities, including diabetes mellitus (22.6%), hypertension (38.1%), and dyslipidemia (20.6%), were significantly more prevalent in MEN1 patients than controls. Mortality was elevated among MEN1 patients (HR 3.69; 95% confidence intervals (CI) 2.56-5.31), particularly those with multiorgan involvement, although hazard ratios varied by organ combination and had wide, overlapping CIs. The mean age at death was significantly younger in MEN1 patients (60.1 years) than in controls (68.0 years).This nationwide cohort study of clinically suspected MEN1 in South Korea reveals a substantial clinical burden, particularly among patients with multiorgan involvement.Enhanced clinical surveillance and early interventions are essential to improve outcomes for MEN1 patients. Future research integrating genetic testing and clinical data is needed to further guide management strategies.

Keywords: Multiple Endocrine Neoplasia Type 1, Epidemiology, Comorbidity, cohort study, Mortality

Received: 17 Jan 2025; Accepted: 30 May 2025.

Copyright: © 2025 Kim, Yu, Hwang, Moon, Hong and Rhee. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yumie Rhee, Yonsei University Health System, Seoul, Republic of Korea

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.